Immunization

Dendritic Cells Predict HBV Vaccination Success

Published in Vaccine Weekly, May 24th, 1999

Animal studies suggest antigen-presenting dendritic cells have prognostic value in determining the success of vaccine therapy in hepatitis B virus carriers.

In this study, researcher S.M. Akbar and colleagues from Japan's Ehime University sought to identify a prognostic marker of vaccine therapy using an animal model of HBV-carrier state, HBV-transgenic mice (Tg) ("Prognostic Importance of Antigen-Presenting Dendritic Cells During Vaccine Therapy in a Murine Hepatitis B Virus Carrier," Immunology, 1999;96(1):98-108).

Neither the prevaccinated titres of viral markers, such as hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg) or HBV...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1999-05-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry